The new study, undertaken by researchers at Oregon Health & Science University and published by Jama Ophthalmology, suggests that GLP-1 drugs such as Ozempic and Monjaro can reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results